Share

    


Home / Search Results

Search Results

You searched for:

The shortage of chemotherapy drugs is placing a considerable burden on cancer care providers. To end this, ACCC is working its members, as well as other provider and patient advocacy organizations, to identify potential policy solutions.
Ochsner Health, Ochsner Cancer Institute developed a program to remotely monitor patients on intravenous or oral anti-cancer treatment.
An expert ACCC Steering Committee shares 32 informed treatment and care delivery recommendations for the ideal care of patients with non-small cell lung cancer.
This ACCC education program shares key highlights from a national survey of thoracic surgeons, radiation oncologists, and medical oncologists on the barriers that exist in the ideal management of patients with NSCLC.
Dr. Vijay Rao and Dr. Eric Stephen Rubenstein returned from a Global Cardio-Oncology Society meeting g with the realization that they could do much more to protect patients with cancer from potential cardiac toxicity of chemotherapy. The two shared one goal: to prevent the cancer survivor of today from becoming the heart failure patient of tomorrow.
In response to the increasing complexity of oncolytic agents, the associated economic burden on the patient and health system, and the intricacies associated with alternative payment models (APMs), I suggest the need for widespread establishment of chemotherapy stewardship services.
Although many rural facilities in South Dakota do have infusion centers that administer anti-cancer therapies, these centers are generally not directly overseen by an oncologist or oncology trained advanced practice provider. Rather, local family practice or internal medicine physicians who are often unfamiliar with oncologic therapies oversee the administration of infusions.
The complexity of head and neck cancer management demands greater attention in order to provide high-quality care. UC San Diego Moores Cancer Center developed a well-defined care pathway to enable predictability and consistency in both care delivery and cost.
Fertility preservation is an increasing concern for adolescent and young adult (AYA) patients with cancer. However, not all newly diagnosed males discuss fertility preservation with a healthcare provider before treatment. This quality improvement project describes the oncofertility program development that was part of a larger goal to develop an AYA oncology program at our institution, the University …
Though the incidence of AIDS-defining cancers has decreased with the use of antiretroviral therapy, numerous studies suggest that non-AIDS-defining cancers (cancers not previously associated with HIV and AIDS) appear to be increasing in incidence.
Long, written descriptions of chemotherapy and its side effects, particularly when prescribing multiple drugs, are often ignored by patients who are overwhelmed by their cancer diagnosis and treatment. From the perspective of the patients, it was clear that all patients needed basic information regarding chemotherapy, including how to react to different situations while on chemotherapy and specifics …